Cargando…

SLCO4A1 is a Prognosis-Associated Biomarker Involved in Neutrophil-Mediated Immunity in Thyroid Cancer

OBJECTIVE: The study aimed to investigate the value of solute carrier organic anion transporter family member 4A1 (SLCO4A1) in thyroid cancer mainly from three aspects: expression, prognosis, and biological function analyses. METHODS: Based on various bioinformatic approaches, genes co-expressed wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xin-Sheng, Wu, Shi-Le, Peng, Zhe, Zhu, Hai-Hong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674671/ https://www.ncbi.nlm.nih.gov/pubmed/34924768 http://dx.doi.org/10.2147/IJGM.S339921

Ejemplares similares

Prognostic Biomarker SLCO4A1 Is Correlated with Tumor Immune Infiltration in Colon Adenocarcinoma
por: Chen, Xiaolong, et al.
Publicado: (2023)

SLCO1A2, SLCO1B1 and SLCO2B1 polymorphisms influences chloroquine and primaquine treatment in Plasmodium vivax malaria
por: Sortica, Vinicius A, et al.
Publicado: (2017)

SLCO4C1 promoter methylation is a potential biomarker for prognosis associated with biochemical recurrence-free survival after radical prostatectomy
por: Li, Xin, et al.
Publicado: (2019)

Developmental Pharmacogenetics of SLCO2B1 on Montelukast Pharmacokinetics in Chinese Children
por: Li, Qian, et al.
Publicado: (2019)

Effects of SLCO1B1 and SLCO1B3 Genetic Polymorphisms on Valsartan Pharmacokinetics in Healthy Korean Volunteers
por: Song, Gonjin, et al.
Publicado: (2021)

Potential involvement of neutrophils in human thyroid cancer
por: Galdiero, Maria Rosaria, et al.
Publicado: (2018)

Neutrophil elastase as a potential biomarker related to the prognosis of gastric cancer and immune cell infiltration in the tumor immune microenvironment
por: Jia, Wangqiang, et al.
Publicado: (2023)

A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics
por: Lehtisalo, Minna, et al.
Publicado: (2022)

Influence of SLCO1B1 in gastric cancer patients treated with EOF chemotherapy
por: Feng, Wanjing, et al.
Publicado: (2018)

The Emerging Role of the SLCO1B3 Protein in Cancer Resistance
por: Sun, Ruipu, et al.
Publicado: (2020)

Toward pharmacogenetic SLCO1B1‐guided dosing of methotrexate in arthritis using a murine Slco1b2 knockout model
por: Taylor, Zachary L., et al.
Publicado: (2021)

Neutrophil extracellular traps and neutrophil-related mediators in human thyroid cancer
por: Modestino, Luca, et al.
Publicado: (2023)

SLCO1B1 Polymorphisms and Statin-Induced Myopathy
por: Stewart, Alison
Publicado: (2013)

Chronic Enteropathy Associated with SLCO2A1 with Pachydermoperiostosis
por: Tsuzuki, Yoshikazu, et al.
Publicado: (2020)

Role of lncSLCO1C1 in gastric cancer progression and resistance to oxaliplatin therapy
por: Xiao, Yu‐Feng, et al.
Publicado: (2022)

Polymorphic variants of SLCO1B1 in neonatal hyperbilirubinemia in China
por: Liu, Jiebo, et al.
Publicado: (2013)

Highly expressed SLCO1B3 inhibits the occurrence and development of breast cancer and can be used as a clinical indicator of prognosis
por: Tang, Tiantian, et al.
Publicado: (2021)

Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma
por: Shi, Yinli, et al.
Publicado: (2023)

Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab
por: Yamauchi, Ichiro, et al.
Publicado: (2019)

Slco2a1 deficiency exacerbates experimental colitis via inflammasome activation in macrophages: a possible mechanism of chronic enteropathy associated with SLCO2A1 gene
por: Nakata, Rieko, et al.
Publicado: (2020)

Pharmacogenomic-guided clozapine administration based on HLA-DQB1, HLA-B and SLCO1B3-SLCO1B7 variants: an effectiveness and cost-effectiveness analysis
por: Ninomiya, Kohei, et al.
Publicado: (2022)

The prognostic value of immune-related genes AZGP1, SLCO5A1, and CTF1 in Uveal melanoma
por: Wang, Wanpeng, et al.
Publicado: (2022)

Neutrophil-to-lymphocyte ratio predicts the prognosis of stage II nasopharyngeal carcinoma
por: Pan, Xin-Bin, et al.
Publicado: (2019)

Loss of SLCO1B3 drives taxane resistance in prostate cancer
por: de Morrée, Ellen S, et al.
Publicado: (2016)

SLCO1B1 genetic variation and hormone therapy in menopausal women
por: Moyer, Ann M., et al.
Publicado: (2018)

Novel SLCO2A1 mutations cause gender-differentiated pachydermoperiostosis
por: Yuan, Lijuan, et al.
Publicado: (2018)

Chronic Enteropathy Associated with Solute Carrier Organic Anion Transporter Family, Member 2A1 (SLCO2A1) with Positive Immunohistochemistry for SLCO2A1 Protein
por: Ariake, Chizuru, et al.
Publicado: (2022)

An integrated pharmacokinetic/pharmacogenomic analysis of ABCB1 and SLCO1B1 polymorphisms on edoxaban exposure
por: Vandell, A G, et al.
Publicado: (2018)

Involvement of Nrf2 in proteasome inhibition-mediated induction of ORP150 in thyroid cancer cells
por: Zong, Zhi-Hong, et al.
Publicado: (2015)

INSC Is a Prognosis-Associated Biomarker Involved in Tumor Immune Infiltration in Colon Adenocarcinoma
por: Zhaoran, Su, et al.
Publicado: (2022)

LncRNA SLCO4A1-AS1 modulates colon cancer stem cell properties by binding to miR-150-3p and positively regulating SLCO4A1
por: Wu, Kun, et al.
Publicado: (2021)

Crohn-like Disease Affecting Small Bowel Due to Monogenic SLCO2A1 Mutations: First Cases of Chronic Enteropathy Associated with SLCO2A1 Gene [CEAS] in France
por: Hamon, Annick, et al.
Publicado: (2022)

Neutrophil extracellular traps and neutrophil-derived mediators as possible biomarkers in bronchial asthma
por: Varricchi, Gilda, et al.
Publicado: (2021)

The Involvement of Neutrophil in the Immune Dysfunction Associated with BVDV Infection
por: Abdelsalam, Karim, et al.
Publicado: (2023)

Effects of tumor size on prognosis in differentiated thyroid carcinoma smaller than 2 cm
por: Zhang, Ting-Ting, et al.
Publicado: (2019)

LncRNA SLCO4A1-AS1 predicts poor prognosis and promotes proliferation and metastasis via the EGFR/MAPK pathway in colorectal cancer
por: Tang, Rui, et al.
Publicado: (2019)

Identification of immune-related lncRNAs to improve the prognosis prediction for patients with papillary thyroid cancer
por: Li, Zhiyang, et al.
Publicado: (2021)

SLCO1B1 and ABCG2 Gene Polymorphisms in a Thai Population
por: Rattanacheeworn, Punyabhorn, et al.
Publicado: (2020)

Ethylmethylhydroxypyridine Succinate Is an Inhibitor but Not a Substrate of ABCB1 and SLCO1B1
por: Shchulkin, Aleksey V., et al.
Publicado: (2023)

Immune-related prognosis biomarkers associated with osteosarcoma microenvironment
por: Hong, Weifeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2eef4j3i4e5vmolaejgau4p9ua